Toyooka S - Search Results

1

Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.

Okumura N, Sonobe M, Okabe K, Nakamura H, Kataoka M, Yamashita M, Nakata M, Kataoka K, Yamashita Y, Soh J, Yoshioka H, Hotta K, Matsuo K, Sakamoto J, Toyooka S, Date H. Okumura N, et al. Among authors: toyooka s. Int J Clin Oncol. 2017 Apr;22(2):274-282. doi: 10.1007/s10147-016-1067-9. Epub 2016 Dec 5. Int J Clin Oncol. 2017. PMID: 27921177

2

Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.

Toyooka S, Tsukuda K, Ouchida M, Tanino M, Inaki Y, Kobayashi K, Yano M, Soh J, Kobatake T, Shimizu N, Shimizu K. Toyooka S, et al. Oncol Rep. 2003 Sep-Oct;10(5):1455-9. doi: 10.3892/or.10.5.1455. Oncol Rep. 2003. PMID: 12883723

3

The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.

Washio K, Aoe M, Toyooka S, Mushiake H, Tsukuda K, Shimizu N. Washio K, et al. Among authors: toyooka s. Oncol Rep. 2003 Nov-Dec;10(6):1967-71. Oncol Rep. 2003. PMID: 14534727

4

The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer.

Konishi J, Toyooka S, Aoe M, Omura Y, Washio K, Tsukuda K, Shimizu N. Konishi J, et al. Among authors: toyooka s. Oncol Rep. 2004 May;11(5):1063-7. doi: 10.3892/or.11.5.1063. Oncol Rep. 2004. PMID: 15069548

5

SYT-SSX fusion genes in synovial sarcoma of the thorax.

Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N, Ichimura K, Aoe M, Date H, Shimizu N. Yano M, et al. Among authors: toyooka s. Lung Cancer. 2004 Jun;44(3):391-7. doi: 10.1016/j.lungcan.2003.11.011. Lung Cancer. 2004. PMID: 15140553 Review.

6

DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.

Hanabata T, Tsukuda K, Toyooka S, Yano M, Aoe M, Nagahiro I, Sano Y, Date H, Shimizu N. Hanabata T, et al. Among authors: toyooka s. Oncol Rep. 2004 Jul;12(1):177-80. Oncol Rep. 2004. PMID: 15201980

7

The relationship between aberrant methylation and survival in non-small-cell lung cancers.

Toyooka S, Suzuki M, Maruyama R, Toyooka KO, Tsukuda K, Fukuyama Y, Iizasa T, Aoe M, Date H, Fujisawa T, Shimizu N, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Br J Cancer. 2004 Aug 16;91(4):771-4. doi: 10.1038/sj.bjc.6602013. Br J Cancer. 2004. PMID: 15266335 Free PMC article.

8

Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer.

Yano M, Ouchida M, Shigematsu H, Tanaka N, Ichimura K, Kobayashi K, Inaki Y, Toyooka S, Tsukuda K, Shimizu N, Shimizu K. Yano M, et al. Among authors: toyooka s. Int J Cancer. 2004 Oct 20;112(1):8-13. doi: 10.1002/ijc.20407. Int J Cancer. 2004. PMID: 15305370 Free article.

9

Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers.

Yano M, Toyooka S, Tsukuda K, Dote H, Ouchida M, Hanabata T, Aoe M, Date H, Gazdar AF, Shimizu N. Yano M, et al. Among authors: toyooka s. Int J Cancer. 2005 Jan 1;113(1):59-66. doi: 10.1002/ijc.20531. Int J Cancer. 2005. PMID: 15386433 Free article.

10

Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.

Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N. Kobatake T, et al. Among authors: toyooka s. Oncol Rep. 2004 Nov;12(5):1087-92. Oncol Rep. 2004. PMID: 15492797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page